Education
About Us
Working with TipRanks
Follow Us
EQL Pharma AB (DE:7JK)
FRANKFURT:7JK
| Mar 22 | Mar 21 | Mar 20 | Mar 19 | Dec 16 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 95.73M | $ 68.83M | $ 36.82M | $ 27.66M | $ 19.72M |
| Operating Income | $ 38.56M | $ 11.44M | $ 3.15M | $ -1.42M | $ 3.55M |
| EBITDA | $ 38.84M | $ 28.72M | $ 7.29M | $ 3.37M | $ 5.11M |
| Net Income | $ 31.55M | $ 10.38M | $ 2.71M | $ -1.51M | $ 3.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 237.89M | $ 198.83M | $ 124.31M | $ 101.90M | $ 63.59M |
| Total Debt | $ 76.10M | $ 18.00M | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 34.90M | $ -8.58M | $ -10.31M | $ -21.69M | $ -27.18M |
| Total Liabilities | $ 114.26M | $ 107.53M | $ 43.39M | $ 23.70M | $ 6.32M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ 19.74M | $ 3.67M | $ -11.40M | $ -10.16M | $ -5.96M |
| Operating Cash Flow | $ 41.83M | $ 58.84M | $ 6.69M | $ 5.92M | $ 1.04M |
| Investing Cash Flow | |||||
| Financing Cash Flow |